Innate Pharma SA-Spons ADRIPHA
13F holders, Q1 2024 (March 31)9holders
1famous investor
$2.88avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings. The largest holders were Exchange Traded Concepts, LLC ($326K), Optiver Holding B.V. ($203K) and Morgan Stanley ($127K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $42K |
| Exits | 0 | $0 |
Ownership 9 holders
| Exchange Traded Concepts, LLC | 0.01% | Add +141.2% | 113,070 | $326K |
| Optiver Holding B.V. | 0.01% | Add +210.8% | 70,564 | $203K |
| Morgan Stanley | 0.00% | Reduce -4.8% | 44,124 | $127K |
| Jane Street Group, LLC | 0.00% | New | 14,554 | $42K |
| Millennium Management | 0.00% | Reduce -11.9% | 10,579 | $30K |
| Barclays PLC | 0.00% | No change | 412 | $1K |
| UBS Group AG | 0.00% | Add +43.8% | 210 | $604 |
| Rhumbline Advisers | 0.00% | No change | 205 | $590 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 200 | $576 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.